Plenary Item 12. Adoption of the report of the Commission on its sixty-fourth session

CHAIR:

we met every evening at 8:00 o’clock to make a wrap up session to plan the next days and that helped. We were always a team so it was team spirit for everybody and I think also and apologize when sometimes by technical reason I couldn’t see you raise the flag or was too late so it was difficult circumstance. Everybody I heard also, if you wake up in the Singapore morning at 4 and you have to be here you are in the night, so it was for everybody. A huge challenge. And then in this circumstance is to have to negotiate most very difficult. So I thank all delegation also for their constructive and for the patients and for the hard work. Thank you. I would request delegations who have comments which relates to editorial and or translation matters to abstain from taking the floor and to provide those comments in writing directly to the secretariat. The same would apply when we come to adopting of the final report. Let me recall the process for the cosponsorship of draft resolutions in line with the revised organizational arrangements agreed upon in silence procedure. Member States who wish to cosponsor draft resolutions can do so by sending a note for ball to the secretariat.

In addition, member states attending in person can rise their plate. Only raise your plates when you are asked to do so. has explained in the precession consultations last friday the 9th of april and also in the committee of the whole this morning that there would only be statements of financial implications issues issued if there are implications in an adoption, a total of four draft proposals, namely revisions of L4, L5 and L6 and unedited revision of L3 that were considered an approved by the Committee of the whole that met from Monday the 12th of April until today Friday the 16th of April 2021.

The first resolution is contained in documents. As a development oriented drug control strategy, including in the context of the Coronavirus disease pandemic and its consequences, this resolution is sponsored by Guatemala, Peru, Thailand and Albania, Brazil, Colombia, Indonesia, Malaysia, Philipines and Portugal. On behalf of the states, members of United Nations that are members of the European Union and Singapore.

Secretariat:

Thank you, Madam Chair. I thank you very much and I invite at the secretariat to inform about the budgetary implications of the resolution. Please. I would like to inform Member States that the adoption of the draft resolution has no implications on the regular budget of the United Nations. Thank you.

CHAIR:

I thank you very much and now I would like to invite the Commission to adopt the resolution. And I don’t see any objections, therefore the resolution is adopted. And now I would like to ask if there are any delegations who would like to who would wish to make statement? Yes please.

United States:

Thank you chair. the United States congratulates the sponsors of this resolution and request to be added to the list of cosponsors. Thank you.

CHAIR:

No. No, then thank you and now I will proceed to this part. Let me repeat if there are any other delegations who would like to join the Co sponsorship of this resolution. OK, thank you.

CHAIR:

Thank you any other delegation. Brazil online. Brazil place online.

BRAZIL:

Brazil would like to confirm is listed as cosponsor

CHAIR:

Is listed. And now I would like to invite Secretariat to introduce the next resolution. Please.

Secretariat:

Thank you, Madam Chair and the next draft proposal is contained in Document L5 ref one, with the title promoting scientific evidence based, quality, affordable and comprehensive drug prevention treatment, sustained recovery and related support services and is sponsored by Albania, Angola, Australia, Brazil, Norway, Portugal on behalf of the states, members of the United Nations that are members of the European Union, Thailand as well as Algeria, Honduras, Mexico, and Philippines. Thank you, Madam Chair. I thank you and I would like to invite the Secretariat to inform about the budgetary implications of this resolution. Thank you.

In accordance with the rules of procedures of the Functional Commissions of ECOSOC, I would like to inform the Member States. Search the activities related to the request with the adoption of the draft resolution would not entail any additional budgetary implication which we got to the regular program budget. Thank you. I thank you very much and with this clarification will proceed to the adoption of the resolution. I invited the Commission to adopt the resolution. And I see no objections there. For the resolution.

now I would like to ask if there are any delegations who would like to make a statement.

UNITED STATES:

Madam Chair United States congratulates the Co sponsors of this resolution and would like to be added to the list of sponsors as well. Thank you. Thank you, it’s noted, and I invite the distinguished Representative of Portugal to take the floor.

Madam Chair distinguished delegates. It’s a great pleasure for me to address the Commission appointed option of the resolution tabled by Portugal and Austria on behalf of the European Union and its Member States. That focuses on promoting scientific evidence based, quality, affordable and comprehensive drug prevention. Treatment sustained recovery and related support services. At the outset, I’d like to thank Austria for recent conditional support from the very beginning of this project, and of course also EU and its Member States for having endorsed resolution as a new proposal at the time Portugal holds the presidency of the Council. Of their community, but also like to express my sincere gratitude to all the other United Nations Member States who have granted their support and decided to construct a sponsor. This important resolution, and I anticipate my special appreciation to those who might still do so. I would also like to thank the Commission that. Under its strong and competent guidance and with the decisive support of the chair of the cow, came to an agreement on resolution L5, but also on several other very important resolutions and decisions from the start, Portugal has recreated its intention to present the relevant. Timely and balanced resolution on a topic that is of major significance. Remoting scientific evidence based comprehensive prevention and treatment services that the light quality and affordability. We also made no secret that you would. We would do our best so that it could gather, grow support from the US. After many hours of fruitful informal consultations and thanks to the active and constructive engagement of a great number of delegations from different parts of the globe, we believe that we have achieved exactly. What we aimed from the very beginning. A text substantial in nature and technically sound while attaining cross regional support. In this regard, I must highlight the approach of all delegations intervening on the negotiations on Resolution L5. They were and then wavering in their commitment to constructively engage. It greatly result that moves us forward while respecting all legitimate differences. The separators does, allowing that the broad constituency can reflect itself upon it. Portugal believes in multilateralism, as we all do, and we hope that this initiative and approach could help, even if so, if slightly. In the direction of mutual understanding and dialogue. In this way it also also finally like to express a special thanks to the Secretariat of the Commission. The conference room management services, as well as to all the staff of the UNODC for all their help and hard work throughout these days. To ensure that we had a successful Chile session, I thank you very much. Thank you and bye

CHAIR:

I give the floor to the delegate of the Russian Federation please. Spicy burger special pretty mobile criteria popularity Portugal go. It’s the provision of a product of Commission.

Russia:

Thank you Madam Chair Japan to comment this important resolution and so we need to join the cosponsor. Thank you. Thank you, any other delegation hold wish to make a statement or to join the cosponsors of the resolution.

United Kingdom:

Kingdom would like to be added to the list of cosponsors and would like to congratulate portable mass resolution. Thank you. I thank you and the distinguished delegate of and Salvador for customer ship. Any other? A delegation who would like to cosponsor the resolution. Now then, let me proceed with the adoption of the next resolution. Everything will be noted please secretary and thank you very much. Madam Chair and the next draft proposal is contained in document L6. Data collection on responses to the harmful effects of the non medical use of Pharmaceuticals containing narcotic drugs, psychotropic substances, annual psychoactive substances and is sponsored by Angola, Australia, Egypt, Kenya, Malaysia, Nigeria, Singapore. Thailand as well as Algeria, Burkina Faso, France, Germany, Indonesia, Mexico and Philippines. Thank you.

CHAIR: 

thank you and I now invite the secretariat to inform about the budgetary implications of this resolution, please. In accordance with the rules of procedures of the functional conditions of ECOSOC. I would like to inform Member States said the activities related to the request contained in the operative paragraphs of the draft resolution would be carried out provided that extra budgetary resources are made available. Hence the adoption of the draft resolutions would not entail any additional budgetary implications which we come to the regular program budget saying humidity. Thank you for this explanation and now I would like to invite the Commission to adopt the resolution I see Nigeria. Please. Yes, thank you,

NIGERIA:

Madam Chair. Before we adopt resolution, there’s a minor amendment that would like to propose to the resolution in all. The fifth line, the reference to controlled medicines. We would like to delete control costs. The resolution is focused on Pharmaceuticals containing narcotic drugs, psychotropic substances or new psychoactive substances, and some of these substances are either controlled or uncontrolled. So I think we inadvertently included the phrase controlled so like to request that control be deleted. Thank you, Madam Chair.

CHAIR:

Allow me see there are comments on this. But I don’t see any comments. Therefore I would propose that we adopt this resolution as already amended. Just now. And I see no objections. Let me then invite the Commission to adopt this resolution, as amended already. Now. That’s the case, so the resolution is adopted. And now I would like to ask the delegations if they would like to if they would like to make statement statements. I see the delegate of the United States and then.

UNITED STATES:

Thank you, Madam Chair. the United States congratulates the sponsors of this resolution and ask to be added to the list of cosponsors. Thank you. I thank you for this and I saw. I thought two gentlemen, I count Indonesia, Indonesia please. Thank you very much. Madam Chair Indonesia has listed as Co-sponsor of this solutions. But please allow me on behalf of the delegation of Indonesia to express our gratitude responses and responsible solutions for their hard work and contribution to this indecision. I thank you.

CHAIR:

Thank you. I see Portugal and then Japan and click here and Nigeria. Very good thing much more please.

PORTUGAL:

Thank you Madam Chair and we would like to congratulation to congratulate the proponents of this resolution in the last like to add our name at nationally to the support of it. Thank you. Thank you and the delegate of Japan please. Thank you, Madam Chair, with Japan. I appreciate the congratulate this important resolution and will join to the cosponsor or of this resolution. Thank you, thank you and I invite the delegate from the cottage where please? Thank you and I invite the delegate of Spain, please.

SPAIN:

Thank you, Madam Chair. I would like to start by thanking the ambassador of Switzerland who was the chair of the cow for his guidance and constructive leadership throughout the costs of exercise. And please allow me to deliver this statement on behalf of the initial cosponsors of this resolution. Algeria Burkina Faso Egypt Kenya and Nigeria and take this opportunity to express our gratitude to all Co sponsors representing all the regions. We would like to thank all the delegations for their robust and constructive participation in the negotiation of this important resolution and their formidable support. The adoption of this resolution else is a significant step in addressing the gap in data collection on the harmful effects and adverse health consequences of the increasing illicit use of Pharmaceuticals, including those beyond medically approved dosage and new psychoactive substances. The gap in data collection is global, but particularly evident in many developing countries where data collection has remained a huge challenge. Without comprehensive scientific evidence based data on all aspects of the world drug problem, it will be difficult if not impossible to have informed an adequate responses. For instance, domestic and international responses to the harmful effects of an increasingly abused substance, for example tramadol. Will be sufficient, if available data from the regions most affected relates only to the seizures and prosecution without important data on the deaths and other adverse health consequences arising from the abuse. This is what L6 will try to address. Madam Chair, one of the key highlights of the resolution is a request to, you know, this is to assist Member States in strengthening and developing their capacity to collect quality data on the harmful effects of nonmedical use of these Pharmaceuticals, including tramadol and new psychotic substances. And to enhance their reporting capabilities for the analysis and dissemination of such data, including by providing technical assistance in conducting national drug use, population surveys on improving data on drug related deaths arising from abuse of these substances. In addition, the resolution requests the unit INCB&WHO to organize expert level discussions on developing best practices in quality data collection on the harmful effects of the illicit use of these substances that you know. This is further requested to continue to include in the annual World Drug Report information. On the extent of the non medical use of this from articles on new psychologist substances, including true information provided by Member States through the Annual Report Questionnaire, to conclude I would like to retrieve the request to donate countries are not Visitation to provide extra budgetary resources for the implementation. Of this important resolution, thank you very much. Madam Chair.

CHAIR:

I thank you. I would like to ask if there are any other delegations that would like to Co sponsored the resolution. I see El Salvador, Qatar, and Portugal? And still some other delegations can inform the Secretariat.

I thank you very much and we proceed with the adoption of the next resolution. I would invite. I would like to invite the Secretariat to introduce the next resolution.

SECRETARIAT

Thank you, Madam Chair and the last draft proposal is contained. In L3F1 and the unedited version, English version has been distributed in the room and also posted online an has a title facilitating access to comprehensive scientific evidence based drugged amount reduction services and related measures. Including for people impacted by social marginalization and sponsored by Canada, Honduras, Malta, Philipines and Uruguay. Thank you Madam Chair. I thank you. I’m now I would like to invite the Secretary to inform us about the budgetary implications of the adoption of this resolution. In accordance with procedures of the functional Commissions of Echo, so I would like to inform Member States said the activities related to the requests. Contained in the operative paragraphs of the resolution would be carried out provided that extra budgetary choices and made available. Hence the adoption of the draft resolution would not entail any additional budgetary implications with regards to the regular program budget. Thank you, Madam Chair. I thank you for this explanation and now I would like to invite the Commission to adopt the resolution. And I see no objections. Therefore the resolution is adopted. Let me now ask at the delegations. Who would wish to make a statement to do so? I see the delegate of Mexico, please.

UNITED STATES

United States congratulates the sponsors of this resolution. I would like to add our list our name to the list of countries cosponsor. Thank you distinguished Delegate of Japan please. Thank you, Madam Chair, so I’d like to express my hour having gratitude to the city’s sister and ambassador, and share with the committee will hold Korea or Canada of the sponsor and so we had a comment that this important resolution and we would like to join through the circle sponsors. Thank you. Thank you and the delegate of Portugal.

PORTUGAL

Please thank you Madam Chair Portugal would like to join a nationally also to the cosponsors of this resolution. Thank you and congratulations to Canada. Thank you, any other delegation wishing Canada, right Canada would like to make a statement. Please you have the floor.

CANADA

Thank you, Madam Chair Canada remain steadfast in our commitment to work together with the international community to continue to improve global health, safety and security. We do so with the highest regard for dignity of humanity and respect for human rights. I would first like to thank the Swiss ambassador for his effective guidance and leadership of the Committee of the whole and his diplomacy and patience in order to accomplish this important task. Allow me also to take this opportunity to thank my own colleagues Bobby John and Paul Williams for their patience and tireless determination to see this resolution through to adoption at this year’s Commission of narcotic drugs. At the same time, Canada would like to thank all delegations for their active engagement in patients over the past week. We would also like to thank the Government of Malta for their support as a Co sponsor as well as other Member States that have indicated their intent to cosponsor this resolution. The work we undertake is is difficult but necessary as we recognize the importance of ensuring equity for people who use drugs. This is why we brought forward a resolution which focuses on facilitating access to demand reduction services and related measures for people impacted by social marginalization. This resolution recognizes that people impacted by social marginalization continue to face additional barriers to accessing drug services, including prevention, early intervention, treatment, care, recovery, rehabilitation, and social reintegration measures. We also recognize from discussions with other delegations that factors such as poverty, housing, education, discrimination and stigma can marginalized individuals which can lead to an increased risk for problematic substance use. We acknowledge that the perspectives and national context may vary between Member States. However, as we can see from the consensus reached on this resolution, there is a common recognition that marginalized populations are disproportionately impacted in accessing services. Canada would also like to echo the comments from several Member States on the importance of recognizing Indigenous peoples and the marginalization they face. Canada will continue to raise this important issue at CND and welcomes support from other Member States to ensure that these discussions remain active. We thank you once again for your efforts and collaboration. Thank you. I thank you and now I would like to to ask the delegations who would like to consider resolution to raise their flags. Thank you. I think you mentioned that already, right? Portugal and the United States, so thank you, thank you, thank you very much. And with this we managed to adopt all the resolutions and I would like to congratulate. United Kingdom please. Add it’s a list of cosponsors and congratulations to Canada for great resolution. Thank you. Thank you. Get the name will be added, so I would like to join all those who congratulated the cosponsors for their resolutions, which will make the friends. And now we will proceed to the adoption of the draft report. But before I give the floor to the Reporter to introduce the draft report. I would like to recall that regarding the format of the report for the 64th session, the Commission in its decision 55-1 decided to make efforts to reduce the length of its annual reports. Bearing in mind the need for such reportes to include resolutions and decisions adopted. Not transmitted by the Commission as well as a brief summary of its deliberations under each agenda item, focusing in particular on policy findings and conclusions reached, and now I would like to invite Miss Begum Norlane of Kurdistan of rapporteur of this Commission. Who introduced the draft report please. You have the floor.

Kurdistan:

Thank you Madam Chair. With your permission. I would like to present the draft report which is contained in seven documents. Is 77C-7-2021 -L1 and Addendum one to six. The basic document L1 contains the chapter on the organization of the session and Administrative Matters document. L1-1 contains the chapter on item three of the agenda and titled General Debate Document L1. Item four of the agenda and titled Strategic Management, Budgetary and Administrative Questions. Documental 1-3 contains the chapter on item five of the agenda and it’s entitled implementation of the International Drug Control Treaties document L1-4. Contains the chapter on item six of the agenda and it’s entitled. Follow up to the implementation at the National, Regional and international levels of all commitments as reflected in the ministerial Declaration of 2019 to address and counter the world Drug Problem document L1 contains the chapter on items seven of the agenda and it’s. Entitled, Interagency Cooperation and Coordination of Efforts in addressing encountering the world drug problem, Documental 1-6 contains the chapter on item eight of the agenda and it’s entitled recommendations of the subsidiary bodies of their Commission. I would like to inform the Commission that the draft report doesn’t cover their continuation of agenda item 8 entitled recommendations of the subsidiary bodies of the Commission during the tense meeting today at noon. The deliberation on agenda item 9 entitled contributions by the Commission to the work of the Economy and Social Council. In line with General Assembly Resolution 72 Slash 305 including follow up to and review and implementation of the 2030 Agenda for Sustainable Development on Agenda Item 10 and titled Provisional Agenda for the 65th Session of the Commission and an agenda.

SECRETARIAT:

Madam Chair, I would now suggest that we proceed with document L1 and then go to addendum by addendum. Thank you, Madam Chair.

CHAIR:

I thank you very much for this introduction and we proceed to the adoption of the parts of of the report. The first part of the report is the Document E – CN 7 – 2021 – L1 refering to organization of the section, an administrative matters. Are there any comments on this document? I see none, so I presume that the Commission wishes to adopt this part of the report. And that’s the case. So the document ECN7- 2021 – L1 is adopted. And now we proceed to the adoption of the second part of the of the report. The document EC-7-2021 – L1 – Addendum 1 refering to general debate. Are there any comments on this document? I see none, so I presume that the Commission is ready to adopt this part of the report. So this part, the document ECN seven 2021 L1 – addendum 1, is there therefore adopted. And now we proceed to the adoption of the next part of the report contained in the document ECN – 2021 – L1 – Addendum 2 refering to strategic management, budgetary and administrative questions. Are there any comments to this part of the report? I see the delegate of the United States, please. You have the floor.

UNITED STATES

Thank you, Madam Chair. I would like to refer to paragraph 10 of this document. The very last sentence. It says one speaker_the importance of understanding the implications that draft resolutions of the Commission had had for both regular budget an extra extra budgetary funds and underline the importance of further discussions in that regard. The United States was the speaker for that. We just wanted to clarify that further discussion should occur in New York and Vienna and ask that that phrase in New York and Vienna be inserted to paragraph 10. Now we do intend to pursue further discussions in both those venues. This has been communicated to the Secretary as well and writing. Thank you, Madam Chair. I thank you for your comments and I invited delegate of the Saudi Arabia to take the floor please.

Let me invite the delegation of Saudi Arabia to indicate in the chat the comments and WHAT  they would like to say they would wish to make. And I call once again upon the delegation of Canada to take the floor Canada online.

CANADA

The Secretariat will distribute the report with this comments and we’ll put it on the silence procedure. But if there are only editorial issues, or Sapporo or minor issues than than we will proceed so. Now I would like to to. Ask the delegation after delegations if there are any other comments on this part of the of the report to document. Add one addendum 2. If. If there are no more comments, then I will assume that the Commission is ready to adopt that part of the report, with the understanding that this substantive comments by Saudi Arabia will be put on this distributed to the Member States and the silence procedure. So I see that’s the wish of the Commission, so this part of the report is adopted. And now we proceed to the adoption of the next part of the report contained in the document ECN-7-2021-L1 Addendum three, relating to implementation of the International Drug Control Treaties. Are there any comments to this part of the report? I see none, so I understand that the Commission is ready to adopt this part of the report, and this is indeed the case, so it’s so decided. And we proceed with the adoption of the next part of the report contained in the document ECN-7-2021 – L1 – Addendum for relating to follow up to the implementation at the National, regional and international levels of all commitments. Ask reflected in the ministerial declaration of 2019 to address the world drug problem. Are there any comments to this document? I see no comment, so I understand that the Commission is ready to adopt this part of the report.. It’s so decided. I thank you very much.

CHAIR:

This part is adopted and we proceed with the adoption of the next part of the document of the report contained in the document. E-CN-7 2021-L-1 Addendum 5 relating to interagency Cooperation and coordination of efforts in addressing and countering the World Drug Report a problem. Are there any comments on this document? I presume that the Commission wishes to adopt that part of the report. It’s so decided. And now we proceed to the adoption of the next part of the report contained in the document. EC-7- 2021 L 1 Addendum 6 relating to interagency Cooperation and coordination of efforts in addressing encountering the world drug problem. Are there any comments on this document?

So excuse, excuse us, let me repeat. Once again, we are now proceeding with the adoption of the part of the report contained in the document ECN -7-2021 and one Addendum 6 refering to recommendations of this subsidiary bodies of the Commission. Are there any comments on this part of the report? I see on there for this part of the report is adopted. We have now approved the report as contained in document L1 and Addenda 6. I will now invite the Commission to adopt the report as a whole. And, I see no objections. Therefore the report as a whole is adopted. And now I have the pleasure to invite Executive Director of the United Nations Office on Drugs and Crime to address the Commission with her closing remarks.

UNODC:

Thank you, ambassador. Excellencies dear colleagues, we have arrived at the successful conclusion of the 64th session of the Commission on Narcotic Drugs. I warmly congratulate the chair and the Extended Bureau for this achievement in the face of continuing challenges posed by the global pandemic. This hybrid session brought together some 1400 participants. From 128 countries, 19 intergovernmental organisations and 72 non governmental organisations, more than 110 speakers participated in the general debate. The dialogue continued through more than 100 side events, all taking place virtually with participants from all over the world. Together over the course of this week, Member States civil society experts, an academia sharpened the focus on what needs to be done to deal with the effects of the COVID-19 crisis on world drug challenges and to work towards recovery that will get us back on track to achieving the Sustainable Development Goals. We saw this focus. In the joint statement adopted by the Commission on Monday to address the impact of the pandemic on efforts to counter the world drug problem. On Wednesday, Member States took a collective decision to place 8 new substances under international control. The Forest solutions adopted at this session further reflect concerns of safeguarding health and welfare, and they offer concrete steps to strengthen access to drug treatment, rehabilitation, and social reintegration services. Alternative development, scientific evidence based prevention and treatment, and responses to nonmedical use of Pharmaceuticals. Just before the start of this session we marked World Health Day, which this year had the theme of HealthEquity help for all in 2021 means ensuring equal access to vaccines. It also means equitable access to internationally controlled substances for pain relief. And other medical and scientific purposes. People need and deserve access to lifesaving treatment, care and other services, including for drug use disorders, HIV, and related diseases. As health systems have come under unprecedented strain in the pandemic, such services have also been disrupted. And I very much welcome the efforts of the Commission to address these urgent problems. Both the covert crisis and the world drug problem, our shared challenges that heightened the need for greater cooperation and shared solutions. We have seen that drug use patterns and trafficking trends have shifted during the pandemic. Dangerous developments observed before the crisis, including the expansion of drug trafficking online and through maritime and waterway routes as well as non medical use of pharmaceutical drugs have accelerated as the crisis has reversed global development progress driven up poverty and heightened vulnerabilities. Criminal groups have anticipated. Unexploited opportunities by the end of 2020, drug trafficking continued in line with pre pandemic trends or even at increased pace. In order to respond effectively, we must also adapt, adapt and innovative and we, in order to respond effectively, we must also adapt and innovate to offer greater support to the people who need it and stop organized crime and drug traffickers from taking advantage of the social and economic fragility. As this jendi joint statement recognizes, Member States have met adversity during the pandemic by developing new approaches to drug prevention and treatment, as well as two related health and social services taking advantage of online platforms and other technologies. You know, DC remains your steadfast partner. In advancing these responses, I thank Member States for recognizing you know DC’s work in the adopted resolutions, which will take forward through our technical assistance tools, guides and flagship World Drug Report from Headquarters, Indiana, as well as from our network of field offices. In turn, we rely on your financial support to enable our office to continue living up to these many responsibilities you have entrusted to us. Distinguished chair excellencies. The energy and spirit that has kept crucial intergovernmental work progressing in Jenna throughout the pandemic, has been very much in evidence over the past week, helping to chart a path forward through an beyond the current crisis. Our determination to leave no one behind this reflected. In the results of this Commission, our efforts to turn commitments into effective action on the ground are reinforced by, you, know, this new corporate strategy and our strategic vision for Africa. In partnership with Member States Civil Society, the private sectors expert, you and entities, regional organisations and all stakeholders you know this. You will advance. Balanced, human, Humane and effective responses to word drug problems and empower youth, women and the marginalized for health and for justice. This morning we joined our host country in remembering and mourning the more than 9500 people in Austria. And the more than 3,000,000 people worldwide who have lost their lives to the virus we can cherish and honor their memory by committing to greater solidarity and support. Including through the work of this Commission to meet the needs of this unprecedented moment. And to build resilience and capacities for the challenges to come. In closing, I would like to congratulate you all once again. I thank you for your dedication and engagement, and I’m grateful to my colleagues at, you know you know this is for their hard work in making this session possible. Thank you.

CHAIR:

I thank you Excellencies, dear friends, it has been the first time that the representative of Poland chaired the Commission on narcotic drugs. I appreciate this honor. I would like to thank you for your joint work for your willingness to make compromises and for your decision to adhere to the discipline of this session. Also, for your constructive approach towards the negotiation of the statement of the Commission and the resolutions, I would like to thank Executive Director, Secretary of the Commission. Director of the DTA, other members of the Secretariat for the Unlimited Readiness to support me in my role as chair and the Commission in its considerations. I also would like to express my personal appreciation. For their systems of the extended grow and the Bureau in the preparations of the session, a special recognition goes obviously to the first vice chair of the Commission. Ambassador Valve gamma, dose brillhart of Switzerland, for having supported me by chairing the Committee of the whole, which was end for his patients. I also would like to thank Ambassador Miguel Camilo Ruiz Blank of Colombia Mr Booker Hammon of Nigeria for having supported me throughout the session and to our upper to miss beginning Nuland of Kurdistan. Colleagues the year 2020-2021 will be remembered as the year dominated by the pandemic, the year which marginalized all other issues. Also health and social related ones, and also those which are even deteriorating. The memories of the 64th session will. Always somehow bring me to this add picture of an empty room and the dialogue of the chair and many other empty chairs. Let me express hope that this session of the Commission, with its adopted documents, will help focus the attention of the international community on issues related to the dissemination of. Balanced approach to drugs based on cooperation and coordination between the law enforcement and supply reduction on one hand and public health on the other. Besides wishing you as splendid isolation tonight, an engineer’s future, I obviously would like to wish you health. And before we leave, let me recall to this end a masterpiece of the Polish Renaissance poetry written by Jan Cohan of Ski and translated by William UT to health. Health your grant fall none understand how splendid you taste until your waist. Then people do greet their teeth and admit when well-being stops, that health is the tops. Nothing stands nearer, nothing is dearer. All of man’s measures, purse and treasures. Also young faces, beauty and Grace is highest positions. Powerful missions are surely alluring, but health is assuring, once it succumbs, the world is the dumps. Health precious jewel, my house and my Greuel are yours to enfold, to laugh and to hold. I thank you very much. Thank you and before I close the meeting I would like to show you a short video from, you know this.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *